Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
OCU-410 by Ocugen for Dry (Atrophic) Macular Degeneration: Likelihood of Approval
OCU-410 is under clinical development by Ocugen and currently in Phase II for Dry (Atrophic) Macular Degeneration. According to GlobalData,...